Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.46
+0.04 (0.62%)
At close: Sep 5, 2025, 4:00 PM
6.36
-0.10 (-1.55%)
After-hours: Sep 5, 2025, 7:10 PM EDT

Aura Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-101.38-86.92-76.41-58.76-35.25-22.21
Upgrade
Depreciation & Amortization
1.181.221.31.180.830.83
Upgrade
Loss (Gain) From Sale of Assets
--0.21-0.020-
Upgrade
Loss (Gain) From Sale of Investments
-2.62-4.66-3.99-0.53--
Upgrade
Stock-Based Compensation
13.0311.728.776.412.310.74
Upgrade
Other Operating Activities
1.551.471.840.970.02-0
Upgrade
Change in Accounts Payable
-0.020.48-1.040.341.05-1.72
Upgrade
Change in Other Net Operating Assets
4.91-3.125.48-4.19-1.37-1.96
Upgrade
Operating Cash Flow
-83.35-79.81-63.85-54.6-32.41-24.32
Upgrade
Capital Expenditures
-0.87-1.25-0.71-1.09-2.13-0.77
Upgrade
Investment in Securities
90.2470.07-113.25-66.78--
Upgrade
Investing Cash Flow
89.3768.82-113.96-67.87-2.13-0.77
Upgrade
Issuance of Common Stock
47.871.697.2995.6379.050.16
Upgrade
Other Financing Activities
23.41----0.02-0.03
Upgrade
Financing Cash Flow
71.281.697.2995.63166.2610.04
Upgrade
Net Cash Flow
77.29-9.39-80.52-26.84131.72-15.06
Upgrade
Free Cash Flow
-84.22-81.06-64.56-55.7-34.54-25.09
Upgrade
Free Cash Flow Per Share
-1.62-1.63-1.63-1.86-6.69-68.33
Upgrade
Levered Free Cash Flow
-49.19-50.17-39.34-33.69-20.52-16.74
Upgrade
Unlevered Free Cash Flow
-49.19-50.17-39.34-33.69-20.52-16.73
Upgrade
Change in Working Capital
4.89-2.644.44-3.85-0.32-3.68
Upgrade
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q